Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
002294.SZ Stock Price Chart
Explore Shenzhen Salubris Pharmaceuticals Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002294.SZ price movements and trends.
002294.SZ Company Profile
Discover essential business fundamentals and corporate details for Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
10 Sept 2009
Employees
3.60K
Website
https://www.salubris.comCEO
Jie Yan
Description
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefuroxime sodium, cefepime hydrochloride, and cefodizime sodium injections, as well as azithromycin dispersible and levetiracetam tablets. In addition, it offers biotechnological drugs, such as recombinant protein and monoclonal antibody drugs. Further, the company is involved in import, licensing-in, and licensing-out medicines for Europe markets. The company was founded in 1998 and is headquartered in Shenzhen, China.
002294.SZ Financial Timeline
Browse a chronological timeline of Shenzhen Salubris Pharmaceuticals Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 20 Aug 2025
Dividend declared on 14 May 2025
A dividend of ¥0.50 per share was announced, adjusted to ¥0.50. The dividend was paid on 14 May 2025.
Earnings released on 21 Apr 2025
EPS came in at ¥0.18 matching the estimated ¥0.18, while revenue for the quarter reached ¥1.06B .
Earnings released on 28 Mar 2025
EPS came in at ¥0.08 falling short of the estimated ¥0.14 by -42.86%, while revenue for the quarter reached ¥1.01B .
Earnings released on 21 Oct 2024
EPS came in at ¥0.15 surpassing the estimated ¥0.13 by +15.38%, while revenue for the quarter reached ¥958.43M .
Earnings released on 26 Aug 2024
EPS came in at ¥0.13 falling short of the estimated ¥0.16 by -18.75%, while revenue for the quarter reached ¥940.24M .
Dividend declared on 19 Jun 2024
A dividend of ¥0.50 per share was announced, adjusted to ¥0.50. The dividend was paid on 19 Jun 2024.
Earnings released on 23 Apr 2024
EPS came in at ¥0.18 matching the estimated ¥0.18, while revenue for the quarter reached ¥1.09B .
Earnings released on 25 Mar 2024
EPS came in at ¥0.09 falling short of the estimated ¥0.11 by -18.18%, while revenue for the quarter reached ¥900.30M .
Earnings released on 30 Oct 2023
EPS came in at ¥0.13 falling short of the estimated ¥0.14 by -7.14%, while revenue for the quarter reached ¥772.02M .
Earnings released on 24 Aug 2023
EPS came in at ¥0.11 surpassing the estimated ¥0.09 by +22.22%, while revenue for the quarter reached ¥796.77M .
Dividend declared on 9 May 2023
A dividend of ¥0.50 per share was announced, adjusted to ¥0.50. The dividend was paid on 9 May 2023.
Earnings released on 19 Apr 2023
EPS came in at ¥0.19 falling short of the estimated ¥0.20 by -5.00%, while revenue for the quarter reached ¥887.51M .
Earnings released on 28 Mar 2023
EPS came in at ¥0.08 falling short of the estimated ¥0.16 by -50.00%, while revenue for the quarter reached ¥933.68M .
Earnings released on 24 Oct 2022
EPS came in at ¥0.18 surpassing the estimated ¥0.15 by +20.00%, while revenue for the quarter reached ¥880.18M .
Earnings released on 9 Aug 2022
EPS came in at ¥0.09 falling short of the estimated ¥0.42 by -78.57%, while revenue for the quarter reached ¥732.91M .
Dividend declared on 27 Apr 2022
A dividend of ¥0.40 per share was announced, adjusted to ¥0.40. The dividend was paid on 27 Apr 2022.
Earnings released on 18 Apr 2022
EPS came in at ¥0.22 surpassing the estimated ¥0.13 by +69.23%, while revenue for the quarter reached ¥935.24M .
Earnings released on 29 Mar 2022
EPS came in at ¥0.12 matching the estimated ¥0.12, while revenue for the quarter reached ¥870.92M , missing expectations by -38.91%.
Earnings released on 25 Oct 2021
EPS came in at ¥0.16 surpassing the estimated ¥0.14 by +14.29%, while revenue for the quarter reached ¥811.15M .
Earnings released on 24 Aug 2021
EPS came in at ¥0.07 falling short of the estimated ¥0.20 by -65.00%, while revenue for the quarter reached ¥610.39M .
Earnings released on 20 Apr 2021
EPS came in at ¥0.15 surpassing the estimated ¥0.13 by +15.38%, while revenue for the quarter reached ¥765.93M .
Earnings released on 30 Mar 2021
EPS came in at -¥0.19 falling short of the estimated ¥0.61 by -131.15%, while revenue for the quarter reached ¥604.35M .
Earnings released on 23 Oct 2020
EPS came in at ¥0.07 falling short of the estimated ¥0.13 by -46.15%, while revenue for the quarter reached ¥598.43M .
002294.SZ Stock Performance
Access detailed 002294.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.